{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:12:59Z","timestamp":1767611579467,"version":"3.40.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.lungcan.2016.07.023","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T12:40:14Z","timestamp":1469277614000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?"],"prefix":"10.1016","volume":"100","clinical-trial-number":[{"clinical-trial-number":"nct02040272","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-9151","authenticated-orcid":false,"given":"Annabel J.","family":"Sharkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"O\u2019Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Nakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Tenconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean A.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2016.07.023_bib0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.athoracsur.2009.05.036","article-title":"Trimodality therapy for malignant pleural mesothelioma","volume":"88","author":"Buduhan","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0010","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"De Perrot","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S1556-0864(15)31583-5","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial","author":"Flores","year":"2006","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0020","first-page":"595","article-title":"5-year prospective results of trimodality treatment for malignant pleural mesothelioma","volume":"47","author":"Pagan","year":"2006","journal-title":"J. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2007.02.004","article-title":"Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results","volume":"57","author":"Rea","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2016.07.023_bib0030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","article-title":"Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial","volume":"36","author":"Van Schil","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0035","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2004.10.071","article-title":"Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","author":"Weder","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","author":"Weder","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0045","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0050","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezt664","article-title":"Predictors of long-term survival following radical surgery for malignant pleural mesothelioma","author":"Nakas","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0055","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy","volume":"71","author":"B\u00f6l\u00fckbas","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2016.07.023_bib0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1010-7940(01)00594-2","article-title":"Trimodality management of malignant pleural mesothelioma","volume":"19","author":"Maggi","year":"2001","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee","volume":"9","author":"Pass","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0075","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.semtcvs.2014.08.003","article-title":"Novel induction therapies for pleural mesothelioma","volume":"26","author":"Donahoe","year":"2014","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2407-13-22","article-title":"Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma","volume":"13","author":"Federico","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2016.07.023_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11748-011-0915-9","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy\u2019s and St. Thomas' hospitals","volume":"60","author":"Bille","year":"2012","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0095","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0100","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0003-4975(96)01228-3","article-title":"Patterns of failure after trimodality therapy for malignant pleural mesothelioma","volume":"63","author":"Baldini","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.thorsurg.2004.06.006","article-title":"Patterns of failure following surgical resection for malignant pleural mesothelioma","volume":"14","author":"J\u00e4nne","year":"2004","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2014.10.128","article-title":"Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma","volume":"149","author":"Baldini","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11748-009-0440-2","article-title":"Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma","volume":"57","author":"Okubo","year":"2009","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural","volume":"9","author":"Pass","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0135","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1097\/JTO.0b013e3182288af9","article-title":"Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma","volume":"6","author":"Lang-Lazdunski","year":"2011","journal-title":"J.Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0140","first-page":"437","article-title":"Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed","volume":"37","author":"Cortes-Dericks","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ejcts\/ezs418","article-title":"Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience","volume":"43","author":"Ried","year":"2013","journal-title":"Eur. J. Cardio Thorac. Surg."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/fon.14.256","article-title":"Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience","volume":"11","author":"Migliore","year":"2015","journal-title":"Futur. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0155","first-page":"482","article-title":"Hyperthermic chemoperfusion of the pleural cavity in the combined treatment for malignant pleural mesothelioma","volume":"60","author":"Levchenko","year":"2014","journal-title":"Vopr. Onkol."},{"key":"10.1016\/j.lungcan.2016.07.023_bib0160","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216304214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216304214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T04:26:25Z","timestamp":1536553585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500216304214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":32,"alternative-id":["S0169500216304214"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.023","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}